SAN DIEGO, CA -- (MARKET WIRE) -- October 10, 2006 -- Tulip BioMed, Inc. (PINKSHEETS: TPBD), a developer of medical devices and patented technologies for use in the living tissue market, including plastic, cosmetic, and orthopedic surgeries, today announced it has signed a letter of intent with Tissue Genesis, Inc., a leading authority in adipose cell therapy and delivery systems.